Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha

被引:79
作者
Kovacs, B
Vassilopoulos, D
Vogelgesang, SA
Tsokos, GC
机构
[1] WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DEPT CLIN PHYSIOL,WASHINGTON,DC 20307
[2] WALTER REED ARMY MED CTR,DEPT CLIN INVEST,WASHINGTON,DC 20307
[3] WALTER REED ARMY MED CTR,DEPT MED,WASHINGTON,DC 20307
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1996年 / 81卷 / 03期
关键词
D O I
10.1006/clin.1996.0192
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation-induced cell death (AICD) plays an important role in the regulation of the immune response by eliminating preactivated and potentially autoreactive cells. To elucidate possible abnormalities of AICD in human systemic lupus erythematosus (SLE), we studied AICD in activated T cells from patients with SLE and normal controls. CD3-mediated cell death was determined in short-term T cell lines by flow cytometry using propidium iodide staining and analysis of DNA subdiploid peak populations. It was found to be significantly lower in T cells from SLE patients compared to cells from normal controls. Anti-Fas mAb-mediated cell death was similar in SLE and control cell lines. CD3-mediated AICD could be blocked in control and SLE T cell lines by an IgG anti-Fas mAb. Indirect immunofluorescence analysis showed statistically significantly less intracellular TNF-alpha in SLE T cells than in control cells. These data show that activated T cells from patients with SLE are relatively resistant to a TCR-mediated death stimulus although they display intact anti-Fas mAb-mediated cell death. Defective antigen-mediated cell death can contribute to increased numbers of activated autoreactive cells in lupus patients. (C) 1996 Academic Press, Inc.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 43 条
  • [1] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [2] AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245
  • [3] HIGH LEVELS OF BCL-2 PROTEIN IN CIRCULATING T-LYMPHOCYTES, BUT NOT B-LYMPHOCYTES, OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARINGER, M
    WINTERSBERGER, W
    STEINER, CW
    KIENER, H
    PRESTERL, E
    JAEGER, U
    SMOLEN, JS
    GRANINGER, WB
    [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (10): : 1423 - 1430
  • [4] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [5] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [6] Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
    CasciolaRosen, L
    Rosen, A
    Petri, M
    Schlissel, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1624 - 1629
  • [7] PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE
    CHENG, JH
    ZHOU, T
    LIU, CD
    SHAPIRO, JP
    BRAUER, MJ
    KIEFER, MC
    BARR, PJ
    MOUNTZ, JD
    [J]. SCIENCE, 1994, 263 (5154) : 1759 - 1762
  • [8] COHEN JJ, 1993, CHEST, V103, pS99
  • [9] COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
  • [10] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)
    DHEIN, J
    WALCZAK, H
    BAUMLER, C
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 373 (6513) : 438 - 441